Nitrous oxide emissions from an intensively cultivated maize-wheat rotation soil in the North China Plain.

W. Ding,Yan-jiang Cai,Z. Cai,K. Yagi,Xunhua Zheng

DOI: https://doi.org/10.1016/J.SCITOTENV.2006.12.026

2007-02-15

Abstract:

What problem does this paper attempt to address?

Long non‑coding RNAs: novel links in respiratory diseases (review).

Yanru Liu,Ruifeng Zhang,Kejing Ying

DOI: https://doi.org/10.3892/mmr.2015.3290

IF: 3.423

2015-01-01

Molecular Medicine Reports

Abstract:Long non-coding RNAs (lncRNAs) represent a surprisingly novel field in mammalian transcriptome research. With the development of RNA sequencing technology and computational methods, lncRNAs have been demonstrated to have important roles in biological processes at the epigenetic, transcription and post-transcriptional levels. In addition, the dysregulation of lncRNAs contributes to numerous diseases, including cancer and cardiovascular diseases. The present review discusses the important functions of lncRNAs in respiratory diseases, highlights the mechanistic roles which underlie lncRNAs in lung cancer as well as considers the current and future potential use of lncRNAs as novel biomarkers and therapeutic targets for the treatment of lung cancer.
Noncoding RNAs in Alcoholic Liver Disease

Hai‐Di Li,Xiao‐Sa Du,Hui‐Min Huang,Xin Chen,Yang,Cheng Huang,Xiao‐Ming Meng,Jun Li

DOI: https://doi.org/10.1002/jcp.28229

2019-01-01

Journal of Cellular Physiology

Abstract:Alcoholic liver disease (ALD) is a complex process with high morbitity and can cause liver dysfunction, which contains a wide spectrum of hepatic lesions, including steatohepatitis, fibrosis, cirrhosis, and eventually hepatocellular carcinoma. To date, the molecular mechanisms for ALD have not been fully explored and an effective therapy is still missing. Overwhelming evidence shows dysregulation of noncoding RNAs (ncRNAs), particularly microRNAs (miRNAs), is correlated with etiopathogenesis and progress of ALD including hepatocyte damage, disrupted lipid metabolism, aggressive inflammatory responses, oxidative stress, programmed cell death, fibrosis, and epigenetic changes induced by alcohol. For example, circulating miRNA‐122 is a marker of hepatocyte damage, and miRNA‐155 is a potential marker of inflammation, indicating their diagnosis therapeutic potential in ALD. In addition, roles for long noncoding RNAs (lncRNAs) and circular RNAs in ALD are being uncovered. Further, circulating ncRNAs and exosome‐derived ncRNAs have attracted more attention lately, suggesting a role in the prevention and treatment of ALD. This review covers the roles of ncRNAs in ALD, and the potential uses as markers for diagnosis and therapeutic options.
Regulatory Long Non-Coding RNAs of Hepatic Stellate Cells in Liver Fibrosis (Review)

Zhengjie Wu,Shunmei Huang,Xiaoqin Zheng,Silan Gu,Qiaomai Xu,Yiwen Gong,Jiaying Zhang,Bin Fu,Lingling Tang

DOI: https://doi.org/10.3892/etm.2021.9782

IF: 2.7

2021-01-01

Experimental and Therapeutic Medicine

Abstract:Liver fibrosis (LF) is a continuous wound healing process caused by numerous chronic hepatic diseases and poses a major threat to human health. Activation of hepatic stellate cells (HSCs) is a critical event in the development of hepatic fibrosis. Long non-coding RNAs (lncRNAs) that are involved in HSC activation, participate in the development of LF and are likely to be therapeutic targets for LF. In the present review, the cellular signaling pathways of LF with respect to HSCs were discussed. In particular, this present review highlighted the current knowledge on the role of lncRNAs in activating or inhibiting LF, revealing lncRNAs that are likely to be biomarkers or therapeutic targets for LF. Additional studies should be performed to elucidate the potential of lncRNAs in the diagnosis and prognosis of LF and to provide novel therapeutic approaches for the reversion of LF.
[Advances in the Role of Exosome-Derived Long Non-Coding RNAs in Hepatocellular Carcinoma].

Cheng Zhou,Changjun Wang

DOI: https://doi.org/10.3760/cma.j.issn.1007-3418.2019.01.019

2019-01-01

Abstract:Exosomes are one kind ofmicrovesicles secreted by living cells.It contains some small non-coding RNAs (microRNA,lncRNA,circRNA,etc.) which play an important role in signal transduction.In addition,they transfer information through circulating small vesicles,regulate epithelial-mesenchymal transition,tumor microenvironment,promote microangiogenesis,regulate tumor immunity,chemoradiation resistance,and regulate cellular energy metabolism pathways,thereby promoting the occurrence,development and metastasis of hepatocellular carcinoma.This article reviews the mechanism of lncRNA in exogenous and in vivo in relation to the occurrence,development and metastasis of hepatocellular carcinoma.
The Paradoxical Functions of Long Noncoding RNAs in Hepatocellular Carcinoma: Implications in Therapeutic Opportunities and Precision Medicine

Duguang Li,Xiaoxiao Fan,Yirun Li,Jing Yang,Hui Lin

DOI: https://doi.org/10.1016/j.gendis.2020.11.014

2022-01-01

Abstract:Hepatocellular carcinoma (HCC) is among the most aggressive and lethal diseases with poor prognosis, worldwide. However, the mechanisms underlying HCC have not been comprehensively elucidated. With the recent application of high-throughput sequencing techniques, a diverse catalogue of differentially expressed long non-coding RNAs (lncRNA) in cancer have been shown to participate in HCC. Rather than being "transcriptional noise," they are emerging as important regulators of many biological processes, including chromatin remodelling, transcription, alternative splicing, translational and post-translational modification. Moreover, lncRNAs have dual effects in the development and progression of HCC, including oncogenic and tumour-suppressive roles. Collectively, recently data point to lncRNAs as novel diagnostic and prognostic biomarkers with satisfactory sensitivity and specificity, as well as being therapeutic targets for HCC patients. In this review, we highlight recent progress of the molecular patterns of lncRNAs and discuss their potential clinical application in human HCC.
Function of the Long Noncoding RNAs in Hepatocellular Carcinoma: Classification, Molecular Mechanisms, and Significant Therapeutic Potentials

Ahmad Khan,Xiaobo Zhang

DOI: https://doi.org/10.3390/bioengineering9080406

2022-01-01

Abstract:Hepatocellular carcinoma (HCC) is the most common and serious type of primary liver cancer. HCC patients have a high death rate and poor prognosis due to the lack of clear signs and inadequate treatment interventions. However, the molecular pathways that underpin HCC pathogenesis remain unclear. Long non-coding RNAs (lncRNAs), a new type of RNAs, have been found to play important roles in HCC. LncRNAs have the ability to influence gene expression and protein activity. Dysregulation of lncRNAs has been linked to a growing number of liver disorders, including HCC. As a result, improved understanding of lncRNAs could lead to new insights into HCC etiology, as well as new approaches for the early detection and treatment of HCC. The latest results with respect to the role of lncRNAs in controlling multiple pathways of HCC were summarized in this study. The processes by which lncRNAs influence HCC advancement by interacting with chromatin, RNAs, and proteins at the epigenetic, transcriptional, and post-transcriptional levels were examined. This critical review also highlights recent breakthroughs in lncRNA signaling pathways in HCC progression, shedding light on the potential applications of lncRNAs for HCC diagnosis and therapy.
Functional long non-coding RNAs in hepatocellular carcinoma

Chen Xie,Song-Yang Li,Jian-Hong Fang,Ying Zhu,Jin-E Yang

DOI: https://doi.org/10.1016/j.canlet.2020.10.042

IF: 9.756

2021-03-01

Cancer Letters

Abstract:<p>Hepatocellular carcinoma (HCC) is a prevalent human malignancy with high morbidity worldwide. Hepatocarcinogenesis is a complex multistep process, and its underlying molecular mechanisms remain largely unknown. Recently, long non-coding RNAs (lncRNAs), a class of newly discovered molecules, have been revealed as essential regulators in the development of HCC. HCC-associated lncRNAs affect multiple malignant phenotypes by modulating gene expression or protein activity. Moreover, the dysregulation of lncRNAs in the liver is also associated with diseases predisposing to HCC, such as chronic viral infection, nonalcoholic steatohepatitis, and liver fibrosis/cirrhosis. A deeper understanding of the lncRNA regulatory network in the multistep processes of HCC development will provide new insights into the diagnosis and treatment of HCC. In this review, we introduce the biogenesis and function of lncRNAs and summarize recent knowledge on how lncRNAs regulate the malignant hallmarks of HCC, such as uncontrolled cell proliferation, resistance to cell death, metabolic reprogramming, immune escape, angiogenesis, and metastasis. We also review emerging insights into the role of lncRNAs in HCC-associated liver diseases. Finally, we discuss the potential applications of lncRNAs as early diagnostic biomarkers and therapeutic targets.</p>

oncology
Long Noncoding RNA: Its Partners and Their Roles in Cancer

Zhenghua Lin,Yong Hu,Shih‐Wei Lai,Meiying Xue,Jian Lin,Yi Qian,Wei Zhuo,Sijing Chen,Jianmin Si,Lu Wang

DOI: https://doi.org/10.4149/neo_2015_103

2015-01-01

Neoplasma

Abstract:RNA transcripts, which do not encode proteins, have received considerable attention in recent years.These non-coding RNAs are classified into two groups: small non-coding RNAs and long non-coding RNAs (lncRNAs).Increasing evidence suggests that lncRNAs are emerging as key regulators in many biological processes.However, knowledge of the underlying mechanisms whereby they act is still limited.Here, we try to elucidate the way that lncRNAs function in the context of DNA, RNA and protein interaction networks.It is noteworthy that lncRNA and another type of non-coding RNA microRNA (miRNA) may 'talk' to each other more frequently than ever expected.Additionally, lncRNAs display aberrant expression profiles in different kinds of cancers, with their potential roles in carcinogenesis and cancer metastasis.We summarize the effect of some cancer related lncRNAs upon tumor biological events, including cell proliferation, apoptosis, invasion and metastasis.Finally, we focus on the clinical value of lncRNAs, considering their potential application in cancer diagnosis, prognosis and therapeutic intervention.
Progress and Prospects of Long Noncoding RNAs (lncrnas) in Hepatocellular Carcinoma.

Chen Li,Jing Chen,Kai Zhang,Bing Feng,Rui Wang,Longbang Chen

DOI: https://doi.org/10.1159/000430109

2015-01-01

Abstract:Hepatocellular carcinoma (HCC) is one of the most frequently occurring cancers with poor prognosis, and novel diagnostic or prognostic biomarkers and therapeutic targets for HCC are urgently required. With the advance of high-resolution microarrays and massively parallel sequencing technology, lncRNAs are suggested to play critical roles in the tumorigenesis and development of human HCC. To date, dysregulation of many HCC-related lncRNAs such as HULC, HOTAIR, MALAT1, and H19 have been identified. From transcriptional "noise" to indispensable elements, lncRNAs may re-write the central dogma. Also, lncRNAs found in body fluids have demonstrated their utility as fluid-based noninvasive markers for clinical use and as therapeutic targets for HCC. Even though several lncRNAs have been characterized, the underlying mechanisms of their contribution to HCC remain unknown, and many important questions about lncRNAs need resolving. A better understanding of the molecular mechanism in HCC-related lncRNAs will provide a rationale for novel effective lncRNA-based targeted therapies. In this review, we highlight the emerging roles of lncRNAs in HCC, and discuss their potential clinical applications as biomarkers for the diagnosis, prognosis, monitoring and treatment of HCC.
Long Noncoding RNAs, New Critical Regulators in Cancer Immunity.

Minjie Wu,Peifen Fu,Lei Qu,Jian Liu,Aifu Lin

DOI: https://doi.org/10.3389/fonc.2020.550987

IF: 4.7

2020-01-01

Frontiers in Oncology

Abstract:Long noncoding RNAs (lncRNAs) play crucial roles in various aspects of cellular functions. Recent studies have revealed that lncRNAs are critical players in the immune system by modulating immune cell differentiation and functions, particularly in cancer immunity. Here we systematically summarize how lncRNAs are involved in different processes of the cancer immunity cycle, including immune cell differentiation, proliferation, trafficking, and infiltration. Moreover, the limitations of the current understanding of lncRNA's functions in cancer immunity are described, such as the complexity of the cancer immunity system, the inclusive functions of lncRNAs in this system, and the associated immune response. In sum, the comprehensive investigation of the roles of lncRNAs in cancer immunity aids in cancer diagnosis and therapies.
Long non-coding RNAs regulate fatty acid and cholesterol metabolism

Lei Kai,Qu Lei,Liu Fangzhou,Hao Ninghui,Chen Jincheng,Liu Jian,Lin Aifu

DOI: https://doi.org/10.1007/s42764-022-00070-5

2022-01-01

Genome Instability & Disease

Abstract:In recent years, long non-coding RNAs (lncRNAs) have emerged as critical players in regulating biological processes at various levels. LncRNAs modulate the target genes through interacting with DNA, RNA, or protein, which have been found to regulate various physiological and pathological activities. Current studies have reported lncRNAs played an important role in lipid metabolism via diverse pathways. Dysregulation of lipid metabolism is closely related to various metabolic diseases, including obesity, fatty liver disease, and cancer. To further understand the mechanisms of lncRNAs in lipid metabolism, we focus on the role of lncRNAs in fatty acid and cholesterol biosynthesis, catabolism, and transferring, aiming to exploit relevant signaling pathways.
The role of long non-coding RNA in hepatocellular carcinoma

Weizheng Liang,Yan Zhao,Qingxue Meng,Wenjie Jiang,Shoulong Deng,Jun Xue

DOI: https://doi.org/10.18632/aging.205523

2024-02-10

Aging

Abstract:Hepatocellular carcinoma (HCC) is a prevalent liver malignancy with complex etiology and generally poor prognosis. Recently, long non-coding RNAs (lncRNAs), non-protein-coding RNA molecules exceeding 200 nucleotides, have emerged as pivotal players in HCC, influencing its initiation, progression, invasion, and metastasis. These lncRNAs modulate gene expression at epigenetic, transcriptional, and post-transcriptional levels, actively participating in the pathological and physiological processes...

cell biology,geriatrics & gerontology,gerontology
Long Non-Coding RNAs in Non-Alcoholic Fatty Liver Disease; Friends or Foes?

Soltanieh, Sina Kalantari,Fateh, Ata,Rajabivahid, Mansour,Dehghani-Ghorbi, Mahmoud

DOI: https://doi.org/10.1007/s12013-024-01555-8

2024-10-10

Cell Biochemistry and Biophysics

Abstract:Metabolic dysfunction-associated fatty liver disease (MAFLD) is a range of conditions that start with the accumulation of fat in the liver (hepatic steatosis) and can progress to more severe stages like steatohepatitis (NASH) and fibrosis without drinking alcohol. Environmental and genetic variables both contribute to MAFLD's development, with various biological processes and mediators involved at every phase. Long non-coding RNAs (lncRNAs) are a class of RNA molecules that are not translated into protein and are over 200 nucleotides long. They can impact genes that encode protein by controlling transcriptional and post-transcriptional procedures. Dysregulation of lncRNA has been connected to several liver diseases, including MAFLD. Recent research has linked lncRNAs to MAFLD pathology in both patients and animal models. However, the roles of most lncRNAs in MAFLD pathology are still not well recognized. This review provides a comprehensive catalog of recently reported lncRNAs in the pathogenesis of MAFLD and summarizes the current knowledge of lncRNAs usage as therapeutic strategies in MAFLD, the most common liver disease. Collectively, lncRNA's targeting could potentially offer a therapeutic approach by modulating MAFLD.

cell biology,biochemistry & molecular biology,biophysics
Long Non-Coding RNAs: an Emerging Powerhouse in the Battle Between Life and Death of Tumor Cells

Xing Xiong,Xingcong Ren,Meng Cai,Jay W. Yang,Xinguang Liu,Jin Yang

DOI: https://doi.org/10.1016/j.drup.2016.04.001

IF: 22.841

2016-01-01

Drug Resistance Updates

Abstract:Long non-coding RNAs (lncRNAs) represent a class of non-protein coding transcripts longer than 200 nucleotides that have aptitude for regulating gene expression at the transcriptional, post-transcriptional or epigenetic levels. In recent years, lncRNAs, which are believed to be the largest transcript class in the transcriptomes, have emerged as important players in a variety of biological processes. Notably, the identification and characterization of numerous lncRNAs in the past decade has revealed a role for these molecules in the regulation of cancer cell survival and death. It is likely that this class of non-coding RNA constitutes a critical contributor to the assorted known or/and unknown mechanisms of intrinsic or acquired drug resistance. Moreover, the expression of lncRNAs is altered in various patho-physiological conditions, including cancer. Therefore, lncRNAs represent potentially important targets in predicting or altering the sensitivity or resistance of cancer cells to various therapies. Here, we provide an overview on the molecular functions of lncRNAs, and discuss their impact and importance in cancer development, progression, and therapeutic outcome. We also provide a perspective on how lncRNAs may alter the efficacy of cancer therapy and the promise of lncRNAs as novel therapeutic targets for overcoming chemoresistance. A better understanding of the functional roles of lncRNA in cancer can ultimately translate to the development of novel, lncRNA-based intervention strategies for the treatment or prevention of drug-resistant cancer.
Emerging roles of long noncoding RNAs in cholangiocarcinoma: Advances and challenges

Yang Yang,Xueting Deng,Quanpeng Li,Fei Wang,Lin Miao,Qi Jiang

DOI: https://doi.org/10.1002/cac2.12109

IF: 15.2825

2020-11-03

Cancer Communications

Abstract:Cholangiocarcinoma (CCA), a cancer with a relatively low incidence rate, is usually associated with poor prognosis. Current modalities for the diagnosis and treatment of CCA patients are still far from satisfactory. In recent years, numerous long noncoding RNAs (lncRNAs) have been identified as crucial players in the development of various cancers, including CCA. Abnormally expressed lncRNAs in CCA, regulated by some upstream molecules, significantly influence the biological behavior of tumor cells and are involved in tumor development through various mechanisms, including interactions with functional proteins, participation in competing for endogenous RNA (ceRNA) regulatory networks, activation of cancer-related signaling pathways and epigenetic modification of gene expression. Furthermore, several lncRNAs are closely associated with the clinicopathological features of CCA patients, and are promising biomarkers for diagnosing and prognostication of CCA. Some of these lncRNAs play an important role in chemotherapy drug resistance. In addition, lncRNAs have also been shown to be involved in the inflammation microenvironment of CCA and malignant outcome of CCA risk factors, such as cholestatic liver diseases. In view of the difficulty of diagnosing CCA, more attention should be paid to detectable lncRNAs in the serum or bile. This review summarizes the recent knowledge on lncRNAs in CCA and provides a new outlook on the molecular mechanisms of CCA development from the perspective of lncRNAs. Moreover, we also discussed the limitations of the current studies and differential expression of lncRNAs in different types of CCA.

oncology
Long non-coding RNAs in hepatocellular carcinoma

Wen-Jun Ge,Huan Huang,Tao Wang,Wei-Hong Zeng,Min Guo,Chen-Ran Ren,Ting-Yu Fan,Fang Liu,Xi Zeng,Wen-jun Ge,Wei-hong Zeng,Chen-ran Ren,Ting-yu Fan

DOI: https://doi.org/10.1016/j.prp.2023.154604

IF: 3.309

2023-08-01

Pathology - Research and Practice

Abstract:Long noncoding RNAs (lncRNAs) refer to a class of RNAs greater than 200 nucleotides in length, most of which are considered unable to encode proteins, thus deemed to be junk genes formerly. But with emerging studies about lncRNAs coming out in recent years, it is much more clearly depicted that they can regulate gene expression at different levels, with various mechanisms, thus participating in diverse biological or pathological processes, including complicated tumor-associated pathways. Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer, the third leading cause of cancer-related mortality worldwide, which has been found to tightly associate with aberrant expression of a variety of lncRNAs regulating tumor proliferation, invasion, drug resistance, and so on, making it a potential novel tumor marker and therapeutic target. In this review, we highlight a few lncRNAs that are closely related to the occurrence and progression of HCC and try to cover their multifarious roles from different layers.

pathology
Long Noncoding RNA Plays a Key Role in Metastasis and Prognosis of Hepatocellular Carcinoma.

Guangbing Li,Haohai Zhang,Xueshuai Wan,Xiaobo Yang,Chengpei Zhu,Anqiang Wang,Lian He,Ruoyu Miao,Shuguang Chen,Haitao Zhao

DOI: https://doi.org/10.1155/2014/780521

2014-01-01

BioMed Research International

Abstract:Long noncoding RNAs (lncRNAs) have been attracting immense research interests. However, only a handful of lncRNAs had been thoroughly characterized. They were involved in fundamental cellular processes including regulation of gene expression at epigenetics as well as tumorogenesis. In this paper, we give a systematic and comprehensive review of existing literature about lncRNA involvement in hepatocellular carcinoma. This review exhibited that lncRNAs played important roles in tumorigenesis and subsequent prognosis and metastasis of hepatocellular carcinoma and elucidated the role of some specific lncRNAs such as MALAT1 and HOTAIR in the pathophysiology of hepatocellular carcinoma and their potential of being therapeutic targets.
The Emerging Role and Promise of Long Noncoding RNAs in Lung Cancer Treatment

Ying Chen,Chen Li,Yan Pan,Siqi Han,Bing Feng,Yanping Gao,Jing Chen,Kai Zhang,Rui Wang,Longbang Chen

DOI: https://doi.org/10.1159/000445575

2016-01-01

Cellular Physiology and Biochemistry

Abstract:Lung cancer is the leading cause of cancer death around the world. The advanced discovery of numerous long noncoding RNAs (lncRNAs) has dramatically changed the understanding of biology of human cancers, including lung cancer. LncRNAs are a group of noncoding RNAs (ncRNAs) with a length greater than 200 nucleotides with limited or no protein-coding capacity. Increasing evidence has shown that specific lncRNAs may be implicated in the process of tumorigenesis. Because of their roles in the regulation of multiple molecular pathways associated with changes in gene expression, lncRNAs can serve as potential diagnostic biomarkers or therapeutic targets in lung cancer. Importantly, dysregulated lncRNAs is reported to be correlated with the sensitivity of lung cancer cells to anticancer therapies, including chemotherapy, molecular-targeted therapy, etc. Herein, we review the recent progress of lncRNAs in lung cancer, with a particular focus on the multiple molecular roles of regulatory lncRNAs on the molecular signaling pathways involved in tumorigenesis and the resistance to such therapies.
Dynamic role of exosomal long non-coding RNA in liver diseases: pathogenesis and diagnostic aspects

Mohammed Ismail,Missaa M. Fadul,Reham Taha,Orwa Siddig,Muhanad Elhafiz,Bashir A. Yousef,Zhenzhou Jiang,Luyong Zhang,Lixin Sun

DOI: https://doi.org/10.1007/s12072-024-10722-1

IF: 9.029

2024-09-23

Hepatology International

Abstract:Liver disease has emerged as a significant health concern, characterized by high rates of morbidity and mortality. Circulating exosomes have garnered attention as important mediators of intercellular communication, harboring protein and stable mRNAs, microRNAs, and long non-coding RNAs (lncRNA). This review highlights the involvement of exosomal lncRNA in the pathogenesis and diagnosis of various liver diseases. Notably, exosomal lncRNAs exhibit therapeutic potential as targets for conditions including hepatic carcinoma, hepatic fibrosis, and hepatic viral infections.

gastroenterology & hepatology
Long Noncoding Rnas In Hepatocellular Carcinoma: Novel Insights Into Their Mechanism

Yong-Ru Liu,Rui-Xue Tang,Wen-Ting Huang,Fang-Hui Ren,Rong-Quan He,Li-Hua Yang,Dian-Zhong Luo,Yi-Wu Dang,Gang Chen

DOI: https://doi.org/10.4254/wjh.v7.i28.2781

2015-01-01

World Journal of Hepatology

Abstract:Hepatocellular carcinoma (HCC) is the predominant subject of liver malignancies which arouse global concern. Advanced studies have found that long noncoding RNAs (IncRNAs) are differentially expressed in HCC and implicate they may play distinct roles in the pathogenesis and metastasis of HCC. However, the underlying mechanisms remain largely unclear. In this review, we summarized the functions and mechanisms of those known aberrantly expressed IncRNAs identified in human HCC tissues. We hope to enlighten more comprehensive researches on the detailed mechanisms of IncRNAs and their application in clinic, such as being used as diagnostic and prognostic biomarkers and the targets for potential therapy. Although studies on IncRNAs in HCC are still deficient, an improved understanding of the roles played by IncRNAs in HCC will lead to a much more effective utilization of those IncRNAs as novel candidates in early detection, diagnosis, prevention and treatment of HCC.

Nitrous oxide emissions from an intensively cultivated maize-wheat rotation soil in the North China Plain.

Long non‑coding RNAs: novel links in respiratory diseases (review).

Noncoding RNAs in Alcoholic Liver Disease

Regulatory Long Non-Coding RNAs of Hepatic Stellate Cells in Liver Fibrosis (Review)

[Advances in the Role of Exosome-Derived Long Non-Coding RNAs in Hepatocellular Carcinoma].

The Paradoxical Functions of Long Noncoding RNAs in Hepatocellular Carcinoma: Implications in Therapeutic Opportunities and Precision Medicine

Function of the Long Noncoding RNAs in Hepatocellular Carcinoma: Classification, Molecular Mechanisms, and Significant Therapeutic Potentials

Functional long non-coding RNAs in hepatocellular carcinoma

Long Noncoding RNA: Its Partners and Their Roles in Cancer

Progress and Prospects of Long Noncoding RNAs (lncrnas) in Hepatocellular Carcinoma.

Long Noncoding RNAs, New Critical Regulators in Cancer Immunity.

Long non-coding RNAs regulate fatty acid and cholesterol metabolism

The role of long non-coding RNA in hepatocellular carcinoma

Long Non-Coding RNAs in Non-Alcoholic Fatty Liver Disease; Friends or Foes?

Long Non-Coding RNAs: an Emerging Powerhouse in the Battle Between Life and Death of Tumor Cells

Emerging roles of long noncoding RNAs in cholangiocarcinoma: Advances and challenges

Long non-coding RNAs in hepatocellular carcinoma

Long Noncoding RNA Plays a Key Role in Metastasis and Prognosis of Hepatocellular Carcinoma.

The Emerging Role and Promise of Long Noncoding RNAs in Lung Cancer Treatment

Dynamic role of exosomal long non-coding RNA in liver diseases: pathogenesis and diagnostic aspects

Long Noncoding Rnas In Hepatocellular Carcinoma: Novel Insights Into Their Mechanism